Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Curis to Present at 31st Annual Piper Jaffray Healthcare Conference


LEXINGTON, Mass., Nov. 26, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, Chief Executive Officer of Curis, will present at the 31st Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2019 at 11:30 a.m. ET in New York, NY.

(PRNewsfoto/Curis, Inc.)

A live webcast of the presentation will be available under "Events & Presentations" in the Investors section of the Company's website at www.curis.com. A replay of the webcast will be available on the Curis website for 90 days following the event.

About Curis, Inc.

Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, including fimepinostat, which is being investigated in clinical studies in patients with DLBCL and solid tumors. Curis is also engaged in a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including, the VISTA/PDL1 antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 trial in patients with non-Hodgkin lymphoma. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedge® for the treatment of advanced basal cell carcinoma. For more information, visit Curis' website at www.curis.com.

SOURCE Curis, Inc.


These press releases may also interest you

at 17:30
Pluribus Technologies Corp. Announces Details of Q4 2023 Financial Results Conference Call
Pluribus Technologies Corp. ("Pluribus" or the "Company"), a growing acquirer of small, profitable technology companies, today announced that Company management will host a conference call to discuss its fiscal 2024 fourth quarter financial results...

at 17:00
SpryPoint Unveils Embedded Payment Solution for SpryCIS and SpryEngage Platforms
SpryPoint, the leading enterprise software-as-a-service (SaaS) provider to Utilities across North America, is proud to announce the upcoming release of SpryWallet, an embedded payment solution designed specifically for the SpryCIS and SpryEngage...

at 16:55
Veterinary Management Groups (VMG) Launches Innovative Veterinary Economic Dashboard
Veterinary Management Groups (VMG) is proud to...

at 16:53
Celebrating Connectivity: telMAX brings Canada's Fastest Internet to The City of Richmond Hill.
telMAX broke ground today in Richmond Hill with the commencement of a state-of-the-art fibre Internet infrastructure project that will deliver all-fibre Internet connectivity to residents and businesses throughout the community....

at 16:35
Bragg Announces US$7 Million Secured Note Financing
Bragg Gaming Group Inc. ("Bragg" or the "Company"), a global B2B gaming technology and content provider, today announced the issuance of a secured promissory note in the principal amount of US$7 million (the "Note") to certain entities controlled by...

at 16:30
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") , an interactive entertainment leader in the Chinese market, today announced its financial results for the year ended December 31, 2023. Fiscal Year 2023 Operating and Financial...

More news about Science and technology...


News published on and distributed by: